Vesleteplirsen (SRP-5051)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vesleteplirsen (SRP-5051), covering 2025-03-10 to 2025-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Expansion (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment [Phase 2]